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ABSTRACT 
 
Cancer research has experienced drastic revolutionizes in the past several years. Completion of the 
human genome project  had signaled a new beginning  for modern biology, where  generating 
information both at the genetic and clinical levels is no  longer the concern. Rather, how this information 
can be handled  has become the major obstacle and barrier to progress. Intuitive  approaches are no 
more feasible to cope with enormous and overwhelming data. The next big step will be to implement 
integrated  modeling approaches to interrogate the massive amount of data  being produced and 
extract useful and valuable answers, which  could help physicians to make an appropriate therapeutic 
decision  making.      Notwithstanding decades of research, the ability to predict  and treat metastatic 
breast cancer is extremely limited and  inadequate (Reuben, Krishnamurthy, Woodward, & Cristofanilli,  
2008). The intricacy to reliably prognosis the risk of breast cancer  metastasis for individual patients 
stems from the fact that cancer is  the result of a complex interplay between numerous factors, namely: 
cellular parameters–altered rates of cell proliferation,  apoptosis, migration, adhesion, metabolism and 
mutation–and  micro-environmental parameters–extracellular matrix (ECM)  composition, angiogenesis, 
inflammation and proteases (Kaiser &  Nasir, 2008). In addition, present breast cancer indices were  
discovered contain some restrictions in order to predict breast  cancer metastasis, since patients with 
identical diagnostic and  clinical prognostic profiles can have apparently diverse clinical  outcome. This 
phenomenon is due to the missing genes cellular  proliferations information in current breast cancer 
indices and a  high reliance on a complex and inexact combination of clinical and  histopathological data 
such as age, tumor size, estrogen and  progesterone receptors, and lymph node involvement. Thus, 
these  indices were notified to provide misleading results as it mainly  group molecularly distinct 
patients into alike clinical classes  generally based on morphological of disease. Although clinical and  
histopathological data are relevance to predict breast cancer  metastasis but gene cellular proliferation 
also is essential  information that needs to be taken into consideration.   These existing restrictions 
reveal the need to apply more  rational approaches to minimize the morbidity and mortality of  
metastatic cancer. Due to the overwhelming flow of data currently  being produced in the biomedical 
sciences and complex interaction  between clinical and gene information in breast cancer invasion  and 
metastasis, an integrated modeling approach is described here.  Bayesian network has been proposed as 
a method to develop an  integrated model for breast cancer prognosis. Bayesian network is  a well 
known technique in biomedical and bioinformatics and  offers several advantages such as it inherently 
model the  uncertainty in the data. It is also a successful combination between  probability theory and 
graph theory. Furthermore, this technique  allows different strategies and data types to be combined. 
